
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5095038
[patent_doc_number] => 20070116647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Medicinal preparation particularly for the treatment of slipped discs hernias'
[patent_app_type] => utility
[patent_app_number] => 10/513592
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1864
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513592 | Medicinal preparation particularly for the treatment of slipped discs hernias | May 6, 2003 | Abandoned |
Array
(
[id] => 7111781
[patent_doc_number] => 20050209237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Method for decreasing capillary permeability in the retina'
[patent_app_type] => utility
[patent_app_number] => 10/512505
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4531
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512505 | Method for decreasing capillary permeability in the retina | Apr 28, 2003 | Abandoned |
Array
(
[id] => 7187963
[patent_doc_number] => 20050192260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 10/473724
[patent_app_country] => US
[patent_app_date] => 2003-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12679
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473724 | Pharmaceutical composition | Apr 20, 2003 | Issued |
Array
(
[id] => 270574
[patent_doc_number] => 07563810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/411656
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15741
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563810.pdf
[firstpage_image] =>[orig_patent_app_number] => 10411656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/411656 | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases | Apr 10, 2003 | Issued |
Array
(
[id] => 7356326
[patent_doc_number] => 20040013723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Oral care capsules'
[patent_app_type] => new
[patent_app_number] => 10/406851
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4758
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406851 | Oral care capsules | Apr 3, 2003 | Abandoned |
Array
(
[id] => 7257189
[patent_doc_number] => 20050143461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Suramin and derivatives thereof as topical microbicide and contraceptive'
[patent_app_type] => utility
[patent_app_number] => 10/508566
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13522
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143461.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508566 | Suramin and derivatives thereof as topical microbicide and contraceptive | Mar 25, 2003 | Issued |
Array
(
[id] => 7018804
[patent_doc_number] => 20050220823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Ophthalmic composition comprising ascomycin'
[patent_app_type] => utility
[patent_app_number] => 10/506233
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3447
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220823.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506233 | Ophthalmic composition comprising ascomycin | Mar 2, 2003 | Abandoned |
Array
(
[id] => 5142527
[patent_doc_number] => 20070004743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Intranasal administration of mc4-r agonists'
[patent_app_type] => utility
[patent_app_number] => 10/505159
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11075
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004743.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505159 | Intranasal administration of mc4-r agonists | Feb 24, 2003 | Abandoned |
Array
(
[id] => 142276
[patent_doc_number] => 07691907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-06
[patent_title] => 'Methods and composition based on discovery of metabolism of nitroglycerin'
[patent_app_type] => utility
[patent_app_number] => 10/508957
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11790
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/691/07691907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508957
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508957 | Methods and composition based on discovery of metabolism of nitroglycerin | Feb 23, 2003 | Issued |
Array
(
[id] => 6918834
[patent_doc_number] => 20050096395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Methods of treating attention deficit/hyperactivity disorder (adhd)'
[patent_app_type] => utility
[patent_app_number] => 10/504435
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16491
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504435 | Methods of treating attention deficit/hyperactivity disorder (adhd) | Feb 11, 2003 | Abandoned |
Array
(
[id] => 7034404
[patent_doc_number] => 20050032914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Lutein/zeaxanthin for glare protection'
[patent_app_type] => utility
[patent_app_number] => 10/503101
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1689
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503101 | Lutein/zeaxanthin for glare protection | Jan 22, 2003 | Abandoned |
Array
(
[id] => 7207993
[patent_doc_number] => 20050043410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders'
[patent_app_type] => utility
[patent_app_number] => 10/502180
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4661
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502180 | Pharmaceutical use of cox-2-inhibitors in angiogenesis-mediated ocular disorders | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6683961
[patent_doc_number] => 20030119825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Highly concentrated stable meloxicam solutions for needleless injection'
[patent_app_type] => new
[patent_app_number] => 10/314586
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2528
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10314586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/314586 | Highly concentrated stable meloxicam solutions for needleless injection | Dec 8, 2002 | Abandoned |
Array
(
[id] => 6684034
[patent_doc_number] => 20030119898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Dosage unit comprising a prostaglandin analog for treating constipation'
[patent_app_type] => new
[patent_app_number] => 10/293516
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4666
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119898.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293516 | Dosage unit comprising a prostaglandin analog for treating constipation | Nov 13, 2002 | Issued |
Array
(
[id] => 7033198
[patent_doc_number] => 20050031707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Saline solutions for clinical or cosmetic use'
[patent_app_type] => utility
[patent_app_number] => 10/490811
[patent_app_country] => US
[patent_app_date] => 2002-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5911
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10490811
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/490811 | Saline solutions for clinical or cosmetic use | Sep 25, 2002 | Issued |
Array
(
[id] => 7351759
[patent_doc_number] => 20040248885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Use of thiazole derivatives for preparing a medicine for protecting mitochondria'
[patent_app_type] => new
[patent_app_number] => 10/483823
[patent_app_country] => US
[patent_app_date] => 2004-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4122
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483823 | Use of thiazole derivatives for preparing a medicine for protecting mitochondria | Jul 24, 2002 | Issued |
Array
(
[id] => 1049727
[patent_doc_number] => 06861043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-01
[patent_title] => 'Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes'
[patent_app_type] => utility
[patent_app_number] => 10/138651
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17844
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138651
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138651 | Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes | May 5, 2002 | Issued |
| 10/068633 | Skin sanitizing antimicrobial alcoholic compositions | Feb 4, 2002 | Abandoned |
Array
(
[id] => 5801405
[patent_doc_number] => 20060035873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Methods for inducing apolipoprotein e secretion'
[patent_app_type] => utility
[patent_app_number] => 10/381111
[patent_app_country] => US
[patent_app_date] => 2001-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6454
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381111 | Methods for inducing apolipoprotein e secretion | Aug 1, 2001 | Abandoned |